As 2023 draws to a close, the pharma industry finds itself at an inflection point. On the one hand, stubbornly high inflation rates, a dearth of talent, supply chain hurdles, and a more challenging regulatory climate threaten profitability. But on the other, the rapid advances in areas ranging from cell and gene therapy and IT…

Single-use instrumentation, especially new pH sensors designed for upstream and downstream applications, are helping manufacturers develop production suites for creating a greater variety of small-run yet highly targeted drugs. Life sciences manufacturers already incorporate leading measurement and automation technologies to ensure the quality of the drugs and medicines they bring to market. Yet because the…

President Biden has instructed FDA to develop a plan to import prescription drugs from Canada while asking federal officials to create a “comprehensive plan” to cut drug prices within 45 days. Biden has also recommended that FTC block “pay for delay” agreements from pharma companies paying generic drug makers to hold off on introducing competitive…